“…For example, the detection or quantification of commonly used redox species is widely demonstrated, covering both inner-and outer-sphere electron transfer reactions that show sensor performance and surface sensitivity. 11,19 Biologically relevant molecules such as glucose or dopamine have also been targeted to directly showcase that FFF has the potential to produce fully personalized biosensors 20,21 with sensitivities in the range of 0.01-0.8 µmol L −1 in dopamine 22,23 and 2.4-36.4 µmol L −1 for glucose, 15,24 and in the case of glucose, ruthenium-based mediators have been employed to ease detection and improve sensitivity. [25][26][27][28][29] These 3D-printed biosensors possess a range of limitations that include: (i) their size, with electrodes up to 10 mm in diameter and several millimeters in thickness, 8,12 (ii) the associated large sample volumes that these dimensions require, 8,12,[30][31][32] and (iii) the restriction of the use of 3D-printing to produce only the working electrode, requiring the use of external counter and reference electrodes that complicate experimental setup and use.…”